Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively

Table 5

Multivariate analysis of survival time of patients with PDAC.

Covariant	coefficient	SE	value	95% confidence interval
Lymph node metastasis	−0.198	0.231	0.009	0.098–1.212
Comprehensive therapy	1.211	0.545	0.045	0.055–2.051
miR-210	0.545	0.594	0.021	0.633–1.098
miR-196a	−1.255	0.051	0.013	0.923–1.055